NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today provided its full-year 2025 guidance (1) and reaffirmed its October 29, 2024 full-year 2024 guidance (1). The ...
* Q2 revenue $24.7 million versus i/b/e/s view $26.3 million * Q2 earnings per share view $0.05 -- Thomson Reuters I/B/E/S * Guidance Software Inc - company has suspended forward looking guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback